Advertisement
Journal Home
Search for
Advanced Search - MEDLINE - My Recent Searches - My Saved Searches - Search Tips
More periodicals:

15 Periodical Search Results

You searched for "oxybutynin" AND "er" OR "receptors, estrogen" OR "endoplasmic reticulum" within European Urology

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

  Viewing 1-15  of 15 results  

Results Page:  [1]

display abstract citation download email a colleague
Display:

  1. Once-Daily, Extended-Release Formulations of Antimuscarinic Agents in the Treatment of Overactive Bladder: A Review
    Eric S. Rovner, Alan J. Wein
    European Urology
    January 2002 (Vol. 41, Issue 1, Pages 6-14)
    Abstract | Full Text | Full-Text PDF (212 KB)

  1. Differential Effects of the Antimuscarinic Agents Darifenacin and Oxybutynin ER on Memory in Older Subjects , 24 April 2006
    Gary Kay, Thomas Crook, Ludmyla Rekeda, Raul Lima, Ursula Ebinger, Miguel Arguinzoniz, Michael Steel
    European Urology
    August 2006 (Vol. 50, Issue 2, Pages 317-326)
    Abstract | Full Text | Full-Text PDF (306 KB)

  1. Long-Term Tolerability of Tolterodine Extended Release in Children 5–11 Years of Age: Results from a 12-Month, Open-Label Study , 11 May 2007
    Rien J.M. Nijman, Niels G. Borgstein, Pamela Ellsworth, Charlotte Siggaard
    European Urology
    November 2007 (Vol. 52, Issue 5, Pages 1511-1517)
    Abstract | Full Text | Full-Text PDF (131 KB)

  1. A Systematic Review and Meta-Analysis of Randomized Controlled Trials with Antimuscarinic Drugs for Overactive Bladder , 07 July 2008
    Giacomo Novara, Antonio Galfano, Silvia Secco, Carolina D’Elia, Stefano Cavalleri, Vincenzo Ficarra, Walter Artibani
    European Urology
    October 2008 (Vol. 54, Issue 4, Pages 740-764)
    Abstract | Full Text | Full-Text PDF (2041 KB)

  1. The Effects of Antimuscarinic Treatments in Overactive Bladder: A Systematic Review and Meta-Analysis , 24 March 2005
    Christopher Chapple, Vik Khullar, Zahava Gabriel, Julie Ann Dooley
    European Urology
    July 2005 (Vol. 48, Issue 1, Pages 5-26)
    Abstract | Full Text | Full-Text PDF (1335 KB)

  1. The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis , 24 June 2008
    Christopher R. Chapple, Vik Khullar, Zahava Gabriel, Dominic Muston, Caty Ebel Bitoun, David Weinstein
    European Urology
    September 2008 (Vol. 54, Issue 3, Pages 543-562)
    Abstract | Full Text | Full-Text PDF (788 KB) | Activate Visual

  1. Reply to Helmut Madersbacher and Klaus-Peter Jünemann's Letter to the Editor re: Christopher R. Chapple, Vik Khullar, Zahava Gabriel, et al. The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis. Eur Urol 2008;54:543–62 , 10 September 2009Online Only
    Christopher Chapple
    European Urology
    December 2009 (Vol. 56, Issue 6, Pages e50-e52)
    Full Text | Full-Text PDF (68 KB)

  1. Long-Term Safety, Tolerability and Efficacy of Extended-Release Tolterodine in the Treatment of Overactive Bladder
    K Kreder, C Mayne, U Jonas
    European Urology
    June 2002 (Vol. 41, Issue 6, Pages 588-595)
    Abstract | Full Text | Full-Text PDF (221 KB)

  1. Re: Christopher R. Chapple, Vik Khullar, Zahava Gabriel, et al. The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis. Eur Urol 2008;54:543–62 , 10 September 2009Online Only
    Helmut Madersbacher, Klaus-Peter Jünemann
    European Urology
    December 2009 (Vol. 56, Issue 6, Pages e48-e49)
    Full Text | Full-Text PDF (66 KB)

  1. Darifenacin, an M3 Selective Receptor Antagonist, is an Effective and Well-Tolerated Once-Daily Treatment for Overactive Bladder
    F Haab, L Stewart, P Dwyer
    European Urology
    April 2004 (Vol. 45, Issue 4, Pages 420-429)
    Abstract | Full Text | Full-Text PDF (186 KB)

  1. Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg , 08 June 2007
    Christopher R. Chapple, Aino Fianu-Jonsson, Mark Indig, Vik Khullar, José Rosa, Roberto M. Scarpa, Arun Mistry, D. Mark Wright, John Bolodeoku, for the STAR study group
    European Urology
    October 2007 (Vol. 52, Issue 4, Pages 1195-1203)
    Abstract | Full Text | Full-Text PDF (483 KB)

  1. Clinical Efficacy, Safety, and Tolerability of Once-Daily Fesoterodine in Subjects with Overactive Bladder , 19 July 2007
    Christopher Chapple, Philip Van Kerrebroeck, Andrea Tubaro, Cornelia Haag-Molkenteller, Hans-Theo Forst, Ute Massow, Joseph Wang, Marina Brodsky
    European Urology
    October 2007 (Vol. 52, Issue 4, Pages 1204-1212)
    Abstract | Full Text | Full-Text PDF (369 KB)

  1. Number of Daytime Micturitions and Volume Voided per Micturition in the Evaluation of Efficacy of Drugs for Overactive Bladder: Findings from Randomized Clinical Trials , 02 April 2007
    Enrico Colli, Fabio Parazzini, Lorenza Olivieri, Sonia Cipriani, Rosanna Bertozzi, Michele Meschia, Francesco Montorsi
    European Urology
    August 2007 (Vol. 52, Issue 2, Pages 525-530)
    Abstract | Full Text | Full-Text PDF (120 KB)

  1. Cizolirtine Citrate, an Effective Treatment for Symptomatic Patients with Urinary Incontinence Secondary to Overactive Bladder: A Pilot Dose-Finding Study , 12 May 2008
    Roberto Martínez-García, Montserrat Abadías, Pere Arañó, Lorenzo Perales, José Luis Ruíz, Mariano Sust, Juan Conejero, for the ESCLIN 006/00 study group
    European Urology
    July 2009 (Vol. 56, Issue 1, Pages 184-192)
    Abstract | Full Text | Full-Text PDF (275 KB)

  1. A Shifted Paradigm for the Further Understanding, Evaluation, and Treatment of Lower Urinary Tract Symptoms in Men: Focus on the Bladder , 17 February 2006
    Christopher R. Chapple, Claus G. Roehrborn
    European Urology
    April 2006 (Vol. 49, Issue 4, Pages 651-659)
    Abstract | Full Text | Full-Text PDF (138 KB)
display abstract citation download email a colleague
Display:

  Viewing 1-15  of 15 results  

Results Page:  [1]

New Search | Edit Search | Save Search | Save Search as an E-mail Alert

Advertisement

Copyright © 2009 Elsevier, Inc. All rights reserved | Privacy Policy | Terms & Conditions | Feedback | About Us | Help | Contact Us |
The content on this site is intended for health professionals.